Literature DB >> 19945449

Hemostatic changes in patients with end stage renal disease undergoing hemodialysis.

Danyelle Romana Alves Rios1, Maria das Graças Carvalho, Bashir A Lwaleed, Ana Cristina Simões e Silva, Karina Braga Gomes Borges, Luci Maria Santana Dusse.   

Abstract

Patients undergoing hemodialysis may show both thrombotic complications and bleeding abnormalities. Hemostatic changes in patients on hemodialysis may result from alterations in vessel wall integrity and platelet function, and reduced blood flow in the native arteriovenous fistula. Vascular complications represent 20-25% of all hospitalizations of patients on hemodialysis. Literature survey revealed that changes in the hemostatic system may play a major role in vascular complications observed in these patients. Thus, it is essential to investigate hemostatic alterations in patients on hemodialysis so that adequate regimes for anticoagulant therapy could be implemented. In this review we discuss hemostatic abnormalities in end stage renal disease patients undergoing hemodialysis. Copyright 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19945449     DOI: 10.1016/j.cca.2009.11.022

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  11 in total

1.  Multidisciplinary evaluation for severity of hazards applied to hemodialysis devices: an original risk analysis method.

Authors:  Carlo Alberto Lodi; Alessandro Vasta; Maria Alquist Hegbrant; Juan P Bosch; Francesco Paolini; Francesco Garzotto; Claudio Ronco
Journal:  Clin J Am Soc Nephrol       Date:  2010-09-02       Impact factor: 8.237

Review 2.  The Biology of Hemodialysis Vascular Access Failure.

Authors:  Akshaar Brahmbhatt; Sanjay Misra
Journal:  Semin Intervent Radiol       Date:  2016-03       Impact factor: 1.513

3.  ADAMTS13 and Von Willebrand factor in patients undergoing hemodialysis.

Authors:  Danyelle R A Rios; Maria G Carvalho; Roberta C Figueiredo; Cláudia N Ferreira; Valério L Rodrigues; Regina A Souza; Ana C Simões e Silva; Ana Paula Fernandes; Karina B Gomes; Luci M S Dusse
Journal:  J Thromb Thrombolysis       Date:  2012-07       Impact factor: 2.300

4.  Alteration of the platelet transcriptome in chronic kidney disease.

Authors:  Hélène Plé; Manon Maltais; Aurélie Corduan; Guy Rousseau; François Madore; Patrick Provost
Journal:  Thromb Haemost       Date:  2012-07-26       Impact factor: 5.249

5.  Primary patency rate of native AV fistula: long term follow up.

Authors:  Kazemzadeh Gh; Modaghegh Mhs; Ravari H; Daliri M; Hoseini L; Nateghi M
Journal:  Int J Clin Exp Med       Date:  2012-04-06

6.  Platelets of patients with chronic kidney disease demonstrate deficient platelet reactivity in vitro.

Authors:  Esther R van Bladel; Rosa L de Jager; Daisy Walter; Loes Cornelissen; Carlo A Gaillard; Leonie A Boven; Mark Roest; Rob Fijnheer
Journal:  BMC Nephrol       Date:  2012-09-28       Impact factor: 2.388

7.  Comment on: Platelet counts and mean platelet volume in association with serum magnesium in maintenance hemodialysis patients.

Authors:  Azar Baradaran
Journal:  J Renal Inj Prev       Date:  2012-01-01

8.  Plasma von Willebrand Factor and a Disintegrin and Metalloproteinase with Eight Thrombospondin-type 1 Motif Levels in Hemodialysis Patients: Relation to Vascular Access Thrombosis.

Authors:  Khaled M A Elzorkany; Belal A M Montaser; Sally M El-Hefnawy
Journal:  Indian J Nephrol       Date:  2018 Jul-Aug

Review 9.  The Pathogenesis of End-Stage Renal Disease from the Standpoint of the Theory of General Pathological Processes of Inflammation.

Authors:  Evgenii Gusev; Liliya Solomatina; Yulia Zhuravleva; Alexey Sarapultsev
Journal:  Int J Mol Sci       Date:  2021-10-23       Impact factor: 5.923

Review 10.  The molecular mechanisms of hemodialysis vascular access failure.

Authors:  Akshaar Brahmbhatt; Andrea Remuzzi; Marco Franzoni; Sanjay Misra
Journal:  Kidney Int       Date:  2016-02       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.